ES489752A0 - Un procedimiento para la preparacion de un derivado de imi- dazolidindiona - Google Patents
Un procedimiento para la preparacion de un derivado de imi- dazolidindionaInfo
- Publication number
- ES489752A0 ES489752A0 ES489752A ES489752A ES489752A0 ES 489752 A0 ES489752 A0 ES 489752A0 ES 489752 A ES489752 A ES 489752A ES 489752 A ES489752 A ES 489752A ES 489752 A0 ES489752 A0 ES 489752A0
- Authority
- ES
- Spain
- Prior art keywords
- imidazolidindiona
- derivative
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/022,400 US4181729A (en) | 1979-03-21 | 1979-03-21 | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES489752A0 true ES489752A0 (es) | 1981-02-16 |
| ES8103058A1 ES8103058A1 (es) | 1981-02-16 |
Family
ID=21809395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES489752A Expired ES8103058A1 (es) | 1979-03-21 | 1980-03-20 | Un procedimiento para la preparacion de un derivado de imi- dazolidindiona |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4181729A (es) |
| EP (1) | EP0017379B1 (es) |
| JP (1) | JPS55127376A (es) |
| AR (1) | AR222695A1 (es) |
| AT (1) | ATE1524T1 (es) |
| AU (1) | AU516325B2 (es) |
| DE (1) | DE3060818D1 (es) |
| DK (1) | DK120780A (es) |
| ES (1) | ES8103058A1 (es) |
| FI (1) | FI800871A (es) |
| GR (1) | GR67200B (es) |
| IE (1) | IE49563B1 (es) |
| IL (1) | IL59615A0 (es) |
| PH (1) | PH13951A (es) |
| PT (1) | PT70981A (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4283409A (en) * | 1979-10-29 | 1981-08-11 | Pfizer Inc. | Imidazolone derivatives |
| AU532110B2 (en) * | 1979-11-13 | 1983-09-15 | Ici Ltd. | Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| US4841078A (en) * | 1982-03-16 | 1989-06-20 | Pfizer Inc. | Benzopyrans |
| US4486428A (en) * | 1982-03-16 | 1984-12-04 | Pfizer Inc. | Bicyclic benzo fused compounds |
| US4863934A (en) * | 1982-03-16 | 1989-09-05 | Pfizer Inc. | Bicyclic benzo fused pyran compounds used for producing analgesia |
| US4870084A (en) * | 1982-03-16 | 1989-09-26 | Pfizer Inc. | Bicyclic benzo fused pyran compounds used for nausea treatment and prevention |
| IL68314A0 (en) * | 1982-04-15 | 1983-07-31 | Alcon Lab Inc | Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds |
| US4464385A (en) * | 1982-04-15 | 1984-08-07 | Alcon Laboratories, Inc. | Treatment of diabetic complications with hydantoins |
| US4436745A (en) | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
| US4438272A (en) | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
| SU1380610A3 (ru) * | 1982-12-06 | 1988-03-07 | Пфайзер Инк. (Фирма) | Способ получени спирогетероазолидиндионов или их фармацевтически приемлемых солей |
| US4556670A (en) * | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
| EP0159143B1 (en) * | 1984-03-23 | 1987-12-16 | Pfizer Inc. | Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications |
| US5340829A (en) * | 1984-11-20 | 1994-08-23 | Washington Research Foundation | Immunoregulatory agents |
| US4966911A (en) * | 1984-11-20 | 1990-10-30 | Washington Research Foundation | Immunoregulatory agents |
| WO1992000071A1 (en) * | 1989-02-10 | 1992-01-09 | Washington Research Foundation | Immunoregulatory agents |
| EP0384416B1 (en) * | 1989-02-22 | 1993-11-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | A pharmaceutical composition containing hydantoin derivative |
| DE10210195B4 (de) | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
| EP3628661A1 (en) * | 2013-06-27 | 2020-04-01 | Lg Chem, Ltd. | Biaryl derivatives as gpr120 agonists |
| US11926601B1 (en) | 2023-08-29 | 2024-03-12 | King Faisal University | 5-spiro 9,10-dihydroanthracene derivative of imidazolidine-2,4-dione as an anticancer agent |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2716648A (en) * | 1955-08-30 | Hydantoin derivatives | ||
| US2872454A (en) * | 1959-02-03 | Spiro-hydantoins from x-chloro- | ||
| DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
| US3532744A (en) * | 1967-07-28 | 1970-10-06 | American Home Prod | 1- and 2-amino substituted indane and tetralene carboxylic acids |
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
| US4189587A (en) * | 1977-04-05 | 1980-02-19 | Ciba-Geigy Corporation | 1,3-Diaminomethyl-hydantoin additives for lubricating oils |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
-
1979
- 1979-03-21 US US06/022,400 patent/US4181729A/en not_active Expired - Lifetime
-
1980
- 1980-03-14 IL IL59615A patent/IL59615A0/xx unknown
- 1980-03-19 PH PH23783A patent/PH13951A/en unknown
- 1980-03-19 AT AT80300821T patent/ATE1524T1/de not_active IP Right Cessation
- 1980-03-19 AR AR280354A patent/AR222695A1/es active
- 1980-03-19 JP JP3574380A patent/JPS55127376A/ja active Granted
- 1980-03-19 EP EP80300821A patent/EP0017379B1/en not_active Expired
- 1980-03-19 DE DE8080300821T patent/DE3060818D1/de not_active Expired
- 1980-03-19 GR GR61496A patent/GR67200B/el unknown
- 1980-03-20 FI FI800871A patent/FI800871A/fi not_active Application Discontinuation
- 1980-03-20 PT PT70981A patent/PT70981A/pt unknown
- 1980-03-20 IE IE571/80A patent/IE49563B1/en unknown
- 1980-03-20 DK DK120780A patent/DK120780A/da not_active Application Discontinuation
- 1980-03-20 AU AU56624/80A patent/AU516325B2/en not_active Ceased
- 1980-03-20 ES ES489752A patent/ES8103058A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI800871A (fi) | 1980-09-22 |
| EP0017379A1 (en) | 1980-10-15 |
| AR222695A1 (es) | 1981-06-15 |
| GR67200B (es) | 1981-06-24 |
| AU516325B2 (en) | 1981-05-28 |
| US4181729A (en) | 1980-01-01 |
| IE49563B1 (en) | 1985-10-30 |
| JPS55127376A (en) | 1980-10-02 |
| IE800571L (en) | 1980-09-21 |
| ATE1524T1 (de) | 1982-09-15 |
| DK120780A (da) | 1980-09-22 |
| ES8103058A1 (es) | 1981-02-16 |
| PT70981A (en) | 1980-04-01 |
| IL59615A0 (en) | 1980-06-30 |
| DE3060818D1 (en) | 1982-10-28 |
| AU5662480A (en) | 1980-09-25 |
| EP0017379B1 (en) | 1982-09-08 |
| JPH0141629B2 (es) | 1989-09-06 |
| PH13951A (en) | 1980-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES505548A0 (es) | Un procedimiento para la preparacion de nuevos derivados de diarilaminofluorano | |
| AR222204A1 (es) | Un procedimiento para la preparacion de derivados de i-bencilimidazol | |
| ES497640A0 (es) | Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina | |
| ES489752A0 (es) | Un procedimiento para la preparacion de un derivado de imi- dazolidindiona | |
| ES501805A0 (es) | Un procedimiento para la preparacion de derivados de la eta-nolamina | |
| ES496798A0 (es) | Un procedimiento para la preparacion de un derivado de aze- tidina | |
| ES495892A0 (es) | Un procedimiento para la preparacion de metacroleina | |
| ES500385A0 (es) | Un procedimiento para la preparacion de derivados de triazo-lopiridazina | |
| ES490510A0 (es) | Un procedimiento para la preparacion de derivados de penici-lina | |
| ES489470A0 (es) | Un procedimiento para la preparacion de 9-aminoalquilfluore-no | |
| ES491370A0 (es) | Un procedimiento para la preparacion de piridizinobenzodiazepinas | |
| ES496487A0 (es) | Un procedimiento para la preparacion de nuevos derivados hi-droxialquil-triazoles | |
| ES493506A0 (es) | Un procedimiento para la preparacion de desacetil-cefalospo-rina c | |
| ES505556A0 (es) | Un procedimiento para la preparacion de derivados de imida- zol | |
| ES490667A0 (es) | Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico | |
| ES495865A0 (es) | Un procedimiento para la preparacion de derivados de quina- zolina | |
| ES491992A0 (es) | Un procedimiento para la preparacion de nuevos derivados de hidroxiamino-eburnano | |
| ES490289A0 (es) | Un procedimiento para la preparacion de derivados de xantina | |
| ES490022A0 (es) | Un procedimiento para la preparacion de imidazobenzodiacepi-nas | |
| ES500381A0 (es) | Un procedimiento para la preparacion de derivados de pirro- lidina | |
| ES495102A0 (es) | Un procedimiento para la preparacion de un derivado de iminohalogenuro | |
| AR222208A1 (es) | Un procedimiento para la preparacion de derivados de 4-amino-2-piperidino-quinazolina | |
| ES491662A0 (es) | Un procedimiento para la preparacion de un pirazol cuaterna-rio | |
| ES489227A0 (es) | Un procedimiento para la preparacion de un derivado de pira-zol | |
| ES490287A0 (es) | Un procedimiento para la preparacion de 2-aminopirazinas |